Personalized medicine and genetic malpractice.
Personalized medicine and genetic malpractice.
复制标题
DOI：
10.1038/gim.2013.142
复制
发表时间：
2013-12
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
评论不断发展，新的护理标准和不同医生的做法之间的差距可以迅速出现，再次导致不同的专家意见的适当做法。只要每一方都能提出至少一位可信的专家，并能指出支持其立场的同行评议研究，这类案件就有可能被提交给陪审团，而陪审团的结果往往是由陪审员的组成和倾向决定的。第三，可能会有许多实际的或被认为是个人化医疗应用不当或错误的受害者。例如，药物不良反应是美国第六大死亡原因，每年造成10万多人死亡，另外还有200多万人住院治疗。[7]由于基因检测可以防止很大一部分的死亡率和发病率，因此在这一领域开展业务的审判律师将可以获得大量潜在的原告。
COMMENTARY evolving, new standards of care and gaps between the practices of different physicians can emerge rapidly, again leading to divergent expert opinions about appropriate practices. As long as each side can present at least one credible expert who can point to peer-reviewed studies supporting their positions, such cases are likely to be presented to the jury, where the outcome will often be a toss-up dictated by the composition and inclinations of individual jurors.Third, there are likely to be many actual or perceived victims of inadequate or erroneous applications of personalized medicine. Adverse drug effects, for example, are the sixth leading cause of death in the United States, accounting for over 100,000 fatalities per year, in addition to more than 2 million hospitalizations. 7 Because genetic testing could arguably prevent a significant fraction of this mortality and morbidity, a large pool of potential plaintiffs will be available to trial lawyers who develop practices in this field.
DOI：
10.1038/gim.2012.168
发表时间：
2013-07
期刊：
Genetics in medicine : official journal of the American College of Medical Genetics
影响因子：
--
作者：
通讯作者：
--
影响因子：
6.7
作者：
Stanek, E. J.;Sanders, C. L.;Frueh, F. W.
通讯作者：
Frueh, F. W.